
Zhejiang Xinguang Pharmaceutical Co., Ltd.
SZSE:300519.SZ
15.16 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | ||||||||||||||
Net Income
| 50.39 | 64.356 | 108.821 | 114.28 | 98.976 | 93.901 | 87.996 | 106.159 | 118.959 | 118.784 | 105.652 | 72.469 | 0 | 0 |
Depreciation & Amortization
| 14.933 | 14.774 | 14.054 | 12.861 | 12.529 | 10.2 | 7.864 | 6.086 | 6.028 | 5.99 | 5.962 | 5.715 | 0 | 0 |
Deferred Income Tax
| 0 | 0 | -0.111 | -0.05 | -0.118 | -0.286 | 0.078 | 0.041 | -0.022 | 0 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| -7.594 | -21.83 | 7.239 | 20.433 | 6.973 | -2.227 | 5.208 | 16.008 | -3.327 | 1.876 | -9.798 | -21.524 | 0 | 0 |
Accounts Receivables
| -2.688 | 14.399 | -8.439 | 2.93 | -0.512 | -1.579 | 10.458 | 9.265 | -2.65 | 5.174 | -22.796 | -9.01 | 0 | 0 |
Inventory
| 1.691 | -25.775 | 0.416 | -4.464 | 6.075 | 5.448 | -11.89 | -2.453 | -10.39 | -2.747 | 0.354 | 0.271 | 0 | 0 |
Accounts Payables
| 0 | -10.603 | 15.372 | 22.017 | 1.528 | -5.81 | 0 | 0 | 9.735 | 0 | 0 | 0 | 0 | 0 |
Other Working Capital
| -6.597 | 0.15 | -0.111 | -0.05 | -0.118 | -0.286 | 17.098 | 18.461 | 7.063 | 4.623 | -10.153 | -21.795 | 0 | 0 |
Other Non Cash Items
| -4.295 | -4.01 | -3.684 | -5.22 | -5.867 | -3.607 | -8.295 | -4.021 | -0.475 | -1.81 | -1.995 | 0.852 | 0 | 0 |
Operating Cash Flow
| 53.434 | 53.29 | 126.429 | 142.355 | 112.612 | 98.266 | 92.772 | 124.232 | 121.185 | 124.84 | 99.82 | 57.511 | 0 | 0 |
Investing Activities: | ||||||||||||||
Investments In Property Plant And Equipment
| -5.2 | -15.987 | -16.645 | -14.713 | -10.269 | -15.995 | -21.267 | -30.401 | -22.27 | -14.84 | -21.845 | -7.222 | -3.017 | -5.831 |
Acquisitions Net
| 0 | 0 | 0.028 | 0.2 | 11.79 | 320 | 0.129 | 0 | 0 | 0 | 0 | 0 | 0 | 0.088 |
Purchases Of Investments
| 0 | 0 | -410 | -415 | -185 | -320 | -340 | -298 | -150 | 0 | -4.8 | 0 | 0 | -13.9 |
Sales Maturities Of Investments
| 580 | 4.292 | 4.549 | 9.977 | 9.363 | 6.592 | 8.315 | 4.076 | 0.707 | 2.814 | 2.811 | 0.409 | 0.035 | 27.01 |
Other Investing Activites
| -604.764 | -39.679 | 420 | 375 | 318 | -40 | -9.871 | -18 | -150 | -0.009 | 7.4 | 0.774 | 17.865 | 37.389 |
Investing Cash Flow
| -29.964 | -51.374 | -2.067 | -44.535 | 143.883 | -49.403 | -22.822 | -44.326 | -171.563 | -12.035 | -16.435 | -6.038 | 14.883 | 44.667 |
Financing Activities: | ||||||||||||||
Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | -2 | -19 | -28 | 40 |
Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| -64 | -80 | -96 | -96 | -72 | -48 | -40 | -40 | -0.046 | -60.063 | -60.073 | -12.681 | -21.062 | -122.413 |
Other Financing Activities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 212.695 | 0 | 0 | 0 | 0 | 1.044 |
Financing Cash Flow
| -64 | -80 | -96 | -96 | -72 | -48 | -40 | -40 | 211.649 | -60.063 | -62.073 | -31.681 | -49.062 | -81.37 |
Other Information: | ||||||||||||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net Change In Cash
| -40.53 | -78.084 | 28.362 | 1.82 | 184.495 | 0.863 | 29.95 | 39.907 | 161.271 | 52.742 | 21.312 | 19.792 | 19.753 | -2.306 |
Cash At End Of Period
| 503.416 | 543.946 | 622.03 | 593.668 | 591.848 | 407.353 | 406.49 | 376.54 | 336.633 | 175.362 | 122.62 | 101.308 | 81.515 | 61.762 |